COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) |
9 Months Ended | |
|---|---|---|
May 08, 2026 |
Mar. 31, 2026 |
|
| Subsidiary, Sale of Stock [Line Items] | ||
| Number of shares granted | 1,500,000 | |
| Cash underwriting discount | $ 600,000 | |
| Deferred fee | $ 600,000 | |
| Underwriters [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Additional shares issued | 40,000 | |
| Over-Allotment Option [Member] | ||
| Subsidiary, Sale of Stock [Line Items] | ||
| Option exercised | $ 1,000,000 | |
| Sale of units in initial public offering | 500,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued as a result of the exercise of stock options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|